Federal Register / Vol. 69, No. 247 / Monday, December 27, 2004 / Notices 77255

The FY 2005 Native Language 

Program Announcement expands the 

Category I—Program Area of Interest 

and the necessary assessment data to be 

collected. ANA recommends each 

applicant consider the Program Area of 

Interest in the development of a project. 

The Program Area of Interest under 

Category I is ‘‘A project for data 

collection and compilation that surveys 

the current language status through a 

‘‘formal’’ method (e.g., work performed 

by a linguist and/or a language survey 

conducted by community members) or 

an ‘‘informal’’ method (e.g., a 

community consensus of the language 

status based on elders, Tribal scholars 

and/or other community members) with 

the development of long-range language 

preservation goals and uses elders in the 

development of these goals. This 

assessment data should capture, at a 

minimum, the following data: number 

of speakers; age of speakers; gender of 

speakers; level(s) of fluency; number of 

first language speakers (native language 

as the first language acquired); number 

of second language speakers (native 

language as the second language 

acquired); where native language is used 

(e.g., home, court system, religious 

ceremonies, church, media, school, 

governance or cultural activities); source 

of data (formal and/or informal); and 

rate of language loss or gain. (Legal 

authority: Section 803(a) and (d) and 

803C of the Native American Programs 

Act of 1974, as amended, 42 U.S.C. 

2991b and 2991b–3.)

Dated: December 17, 2004. 

Quanah Crossland Stamps, 

Commissioner, Administration for Native 

Americans

[FR Doc. 04–28216 Filed 12–23–04; 8:45 am] 

BILLING CODE 4184–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2003D–0497]

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Guidance for Industry on 

Pharmacogenomics Data Submissions

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Guidance for Industry on 

Pharmacogenomics Data Submissions’’

has been approved by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Karen Nelson, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1482.

SUPPLEMENTARY INFORMATION: In the 

Federal Register of August 11, 2004 (69 

FR 48876), the agency announced that 

the proposed information collection had 

been submitted to OMB for review and 

clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0557. The 

approval expires on December 31, 2007. 

A copy of the supporting statement for 

this information collection is available 

on the Internet at http://www.fda.gov/

ohrms/dockets.

Dated: December 17, 2004.

Jeffrey Shuren,

Assistant Commissioner for Policy.

[FR Doc. 04–28134 Filed 12–23–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004N–0166]

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Infant Feeding Practices Study II

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Infant Feeding Practices Study II’’ has 

been approved by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Peggy Robbins, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1223.

SUPPLEMENTARY INFORMATION: In the 

Federal Register of October 1, 2004 (69 

FR 58915), the agency announced that 

the proposed information collection had 

been submitted to OMB for review and 

clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0558. The 

approval expires on December 31, 2007. 

A copy of the supporting statement for 

this information collection is available 

on the Internet at http://www.fda.gov/

ohrms/dockets.

Dated: December 17, 2004.

Jeffrey Shuren,

Assistant Commissioner for Policy.

[FR Doc. 04–28136 Filed 12–23–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004N–0541]

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Exports: 

Notification and Recordkeeping 

Requirements

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the notification and recordkeeping 

requirements for persons exporting 

human drugs, biological products, 

devices, animal drugs, food, and 

cosmetics that may not be marketed or 

sold in the United States.

DATES: Submit written or electronic 

comments on the collection of 

information by February 25, 2005.

ADDRESSES: Submit electronic 

comments to http://www.fda.gov/

dockets/ecomments. Submit written 

comments to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document.

FOR FURTHER INFORMATION CONTACT:

Jonna Capezzuto, Office of Management 

Programs (HFA–250), Food and Drug